Recro Pharma

^{Priced, Nasdaq: REPH}

Clinical-stage biotech developing non-opioid therapeutics for the treatment of pain.

Industry: Health Care

First Day Return: +3.8%

REPH

Clinical-stage biotech developing non-opioid therapeutics for the treatment of pain.

IPO News for Recro Pharma

US IPO Recap: Coupons.com jumps 88% and Biomet files for an IPO 03/10/14
Recro Pharma prices IPO at $8, below the range 03/07/14
3 US IPOs planned for the week of Mar 3 03/03/14

IPO Data
IPO Date	03/06/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$30
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.recropharma.com
Headquarters	Malvern, PA, United States
Founded	2008
Employees at IPO	5

IPO News for Recro Pharma

US IPO Recap: Coupons.com jumps 88% and Biomet files for an IPO 03/10/14
Recro Pharma prices IPO at $8, below the range 03/07/14
3 US IPOs planned for the week of Mar 3 03/03/14

Recro Pharma (REPH) Performance